(1)
Sholzberg, M.; Gwathmey, K.; Broome, C. M.; Goebeler, M.; Murai, H.; Bata-Csörgo, Z.; Newland, A.; Ulrichts, P.; Kerstens, R.; Guptill, J. T.; Agha, S.; Jiang, M.; Howard Jr, J. F. Overview of the Safety Profile From Efgartigimod Clinical Trials in Participants With Diverse IgG-Mediated Autoimmune Diseases. J of Skin 2024, 8, s344.